European Urology Open Science
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
EAU PCa Guideline Panel: Systematic review of focal ablative therapy for localised prostate cancer compared with standard therapies
2020
-
Management of urinary retention in patients with benign prostatic obstruction: A systematic review and meta-analysis
2019
-
How to resolve discrepancies when findings from randomized controlled trials and meta-analyses disagree?
2018
-
Is nonoperative management the best first-line option for high-grade renal trauma? A systematic review
2018
-
Key steps in conducting systematic reviews for underpinning clinical practice guidelines: Methodology of the European Association of Urology
2018
-
692 Systematic review of tract sizes in miniaturized percutaneous nephrolithotomy
2016
-
945 ORAL APOCYNIN SENSITIZES PROSTATE CANCER XENOGRAFTS TO RADIATION
2011
-
587 ANTERIOR PROSTATE BIOPSIES REVEAL A SANCTUARY SITE OF PROSTATE CANCER IN PATIENTS WITH PREVIOUS NEGATIVE EXTENDED PROSTATE BIOPSIES
2010
-
860 WHAT CAN THE HAIR FOLLICLES AND SALIVARY GLANDS TELL US ABOUT THE OXIDATIVE STRESS STATUS OF THE PROSTATE? A PRECLINICAL STEP TOWARDS INDIVIDUALIZATION OF PROSTATE CANCER PREVENTION STRATEGIES
2010
-
NON-RISK ADAPTED SURVEILLANCE IN STAGE I NONSEMINOMATOUS GERM CELL TUMOURS (NSGCT): IMPROVED RECENT OUTCOMES
2008
-
SORAFENIB THERAPY IN THE MANAGEMENT OF ADVANCED RENAL CELL CARCINOMA WITH BRAIN METASTASES: RESULTS FROM THE ARCCS EXPANDED ACCESS PROGRAM
2008
-
Clinical Endpoints for Assessing Bisphosphonate Efficacy in the Prevention of Skeletal Complications of Bone Metastases
2004
-
Protocol for a Series of Systematic Reviews and Network Meta-analyses of Randomized Controlled Trials of Medications for Patients with Overactive Bladder Symptoms..
69:89-99.
2024
-
Practice Variation in the Management of Adult Hydroceles: A Multinational Survey.
58:1-7.
2023
-
The Benefits and Harms of Pharmacological Treatment for Postradiation Pelvic Pain: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel with Recommendations for Clinical Practice.
56:29-38.
2023
-
Is a Course of Intermittent Self-dilatation with Topical Corticosteroids Superior at Stabilising Urethral Stricture Disease in Men and Improving Functional Outcomes over a Course of Intermittent Self-dilatation Alone? A Systematic Review and Meta-analysis.
51:95-105.
2023
-
A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer.
48:1-11.
2023
-
Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer?.
30:44-46.
2021
-
Utilising an Accelerated Delphi Process to Develop Guidance and Protocols for Telepresence Applications in Remote Robotic Surgery Training.
22:23-33.
2020
-
A systematic review of heterogeneity in outcome definition and reporting in Non-Muscle Invasive Bladder Cancer (NMIBC) effectiveness trials of adjuvant treatment after transurethral resection.
19:e1788-e1788.
2020
-
Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction: A Cochrane systematic review and meta-analysis.
19:e2149-e2149.
2020
-
Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection.
19:e514-e515.
2020
-
Clinical significance of the Siaα2,3gal-glycosylated prostate-specific antigen assay for prostate cancer detection.
19:e510-e511.
2020
-
Is there outcome reporting heterogeneity in trials which aim to assess the effectiveness of surgical treatments for stress urinary incontinence in women?.
19:e1811-e1811.
2020
-
Radical cystectomy: The significance of hospital volume and surgeon volume. A systematic review and recommendations by the EAU MIBC Guideline Panel.
19:e1790-e1791.
2020
-
The prevalence of cardiovascular disease and its risk factors among prostate cancer patients treated with and without androgen deprivation.
19:e2106-e2106.
2020
-
What is the prognostic importance of urothelial and non-urothelial histological variants of bladder cancer in predicting oncological outcomes in patients with muscle-invasive and metastatic bladder cancer? Systematic review.
19:e1785-e1786.
2020
-
Clinical significant prostate cancer diagnostic performance of LacdiNAc-prostate-specific antigen glycoisomer assay at initial prostate biopsy: Retrospective multi-institutional study.
18:e141-e142.
2019
-
Investigating a novel recombinant antibody to attenuate prostate cancer progression by targeting cell surface GRP78.
18:e1336-e1336.
2019
-
Prostate cancer-derived anti-GRP78 autoantibodies compromise the blood-brain barrier and accelerate atherosclerosis progression in vivo.
18:e1155-e1155.
2019
-
Active surveillance magnetic resonance imaging study (ASIST): Results of a prospective, multicentre, randomized trial.
17:e1711-e1712.
2018
-
Comparison with diagnostic performance between aberrant glycosylated S2,3PSA test and conventional PSA tests.
17:e552-e554.
2018
-
Decision aids for prostate cancer screening choice: A systematic review and meta-analysis.
17:e381-e382.
2018
-
Disrupting the interaction between anti-GRP78 autoantibodies and cell surface GRP78 with low molecular weight heparin as a treatment for prostate cancer.
17:e509-e509.
2018
-
Impact of posterior urethrovesical reconstruction on early return to continence after robot-assisted radical prostatectomy (RARP): Results of prospective, single-blind, parallel-group, randomized controlled trial.
17:e977-e977.
2018
-
Nomogram-based risk prediction of local and distant relapse after radical cystectomy, and role of perioperative chemotherapy, in patients with muscle-invasive bladder cancer (MIBC): A multicenter study.
17:e519-e520.
2018
-
Prognostic performance and reproducibility of the 1973 and 2004/2016 WHO grading classification systems in non-muscle-invasive bladder cancer: A European Association of Urology non-muscle invasive bladder cancer guidelines panel systematic review.
17:e1719-e1720.
2018
-
Testicular tumour size and rete testis invasion as prognostic factors for the risk of relapse of clinical stage I seminoma testis patients under surveillance: A systematic review by the Testicular Cancer Guidelines Panel.
17:e1740-e1741.
2018
-
What are core outcome sets, how should they be developed and why are they essential for urology?.
17:e1725-e1725.
2018
-
Pattern of relapse after perioperative chemotherapy and radical cystectomy versus radical cystectomy alone in patients with muscle-invasive bladder cancer (MIBC): A multicenter study.
16:e2794-e2795.
2017
-
Cell surface GRP78 activation by anti-GRP78 autoantibodies confers prostate tumour growth via tissue factor activation.
16:e157-e158.
2017
-
Procedure-specific risks of thrombosis and bleeding in urological cancer surgery: Systematic reviews and meta-analyses.
16:e1033-e1034.
2017
-
96 Procedure-specific risks of thrombosis and bleeding in urological cancer surgery: Systematic reviews and meta-analyses.
15:e1259.
2016
-
596 Treatment and clinical outcomes of patients with teratoma with somatic-type malignant transformation (TMT): An international collaboration.
14:e596-e596a.
2015
-
308 The role of FSH in castration-induced weight gain and cardiovascular disease: Differences between orchiectomy, GnRH agonists and antagonists.
13:e308-e308.
2014
-
P119 Design of a randomized, open-label trial adding custirsen, a novel clusterin inhibitor, to cabazitaxel/prednisone in second-line treatment of metastatic Castration-Resistant Prostate Cancer (mCRPC): The AFFINITY phase 3 study.
12:177-177.
2013
-
939 ERp46 mediates prostate cancer tumorigenesis in vitro by inhibiting adiponectin-induced tumor-suppressive effects – linking obesity to prostate cancer.
12:e939-e939.
2013
-
935 ROLE OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3) IN STRETCH INJURY TO BLADDER SMOOTH MUSCLE CELLS.
6:256-256.
2007
-
MAGNETIC RESONANCE IMAGE-GUIDED ROBOT FOR PROSTATE BRACHYTHERAPY.
5:334-334.
2006
-
PROSTATE CANCERS SCORED AS GLEASON 6 IN PROSTATE BIOPSY ARE FREQUENTLY GLEASON 7 TUMOURS AT RADICAL PROSTATECTOMY: IMPLICATION ON OUTCOME.
5:315-315.
2006
-
SECOND MESSENGER PATHWAYS FOLLOWING DETRUSOR M3 RECEPTOR STIMULATION.
5:41-41.
2006
-
THE SIGNIFICANCE OF NEGATIVE AMACR STAINING IN PROSTATE CANCER: SORTING NEUROENDOCRINE PROSTATIC CANCER IN CHALLENGING DIAGNOSTIC CASES.
5:241-241.
2006
-
34 Telerobotic PCNL: It works both ways.
3:11-11.
2004
-
A randomised controlled trial of human versus telerobotic access to the kidney during percutaneous nephrolithotomy.
2:198-198.
2003
-
Is telesurgery a new reality? Our experience in laparoscopic and percutaneous procedures.
1:7-7.
2002
-
Percutaneous access to the kidney using PAKY: our experience in telesurgery.
1:194-194.
2002
has subject area
Identity
International Standard Serial Number (ISSN)
-
1569-9056
-
2666-1683
-
2666-1691
Electronic International Standard Serial Number (EISSN)